Asa SL, Mete O, Perry A, Osamura RY. Overview of the 2022 WHO classification of Pituitary tumors. Endocr Pathol. 2022;33:6–26.

Article  CAS  PubMed  Google Scholar 

Molitch ME. Diagnosis and treatment of Pituitary adenomas: a review. JAMA. 2017;317:516–24.

Article  PubMed  Google Scholar 

de Rotte AAJ, Groenewegen A, Rutgers DR, Witkamp T, Zelissen PMJ, Meijer FJA, et al. High resolution pituitary gland MRI at 7.0 tesla: a clinical evaluation in Cushing’s disease. Eur Radiol. 2016;26:271–7.

Article  PubMed  Google Scholar 

Erickson D, Erickson B, Watson R, Patton A, Atkinson J, Meyer F, et al. 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing’s syndrome. Clin Endocrinol (Oxf). 2010;72:793–9.

Article  CAS  PubMed  Google Scholar 

Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, et al. Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9:847–75.

Article  PubMed  PubMed Central  Google Scholar 

MacFarlane J, Bashari WA, Senanayake R, Gillett D, van der Meulen M, Powlson AS, et al. Advances in the imaging of Pituitary tumors. Endocrinol Metab Clin North Am. 2020;49:357–73.

Article  PubMed  Google Scholar 

Iglesias P, Cardona J, Díez JJ. The pituitary in nuclear medicine imaging. Eur J Intern Med. 2019;68:6–12.

Article  CAS  PubMed  Google Scholar 

Tjörnstrand A, Casar-Borota O, Heurling K, Schöll M, Gjertsson P, Ragnarsson O, et al. Pre- and postoperative 68 Ga-DOTATOC positron emission tomography for hormone-secreting pituitary neuroendocrine tumours. Clin Endocrinol (Oxf). 2021;94:956–67.

Article  PubMed  Google Scholar 

Novruzov F, Aliyev A, Wan MYS, Syed R, Mehdi E, Aliyeva I, et al. The value of [68Ga]Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors. Eur J Hybrid Imaging. 2021;5:10.

Article  PubMed  PubMed Central  Google Scholar 

Gillett D, MacFarlane J, Bashari W, Crawford R, Harper I, Mendichovszky IA, et al. Molecular Imaging of Pituitary tumors. Semin Nucl Med. 2023;53:530–8.

Article  PubMed  Google Scholar 

Bauman MMJ, Graves JP, Harrison DJ, Hassett LC, Bancos I, Johnson DR, et al. The utility of PET for detecting corticotropinomas in Cushing disease: a scoping review. Neurosurg Rev. 2023;46:160.

Article  PubMed  Google Scholar 

Koulouri O, Hoole AC, English P, Allinson K, Antoun N, Cheow H, et al. Localisation of an occult thyrotropinoma with 11 C-methionine PET-CT before and after somatostatin analogue therapy. Lancet Diabetes Endocrinol. 2016;4:1050.

Article  PubMed  Google Scholar 

Koulouri O, Kandasamy N, Hoole AC, Gillett D, Heard S, Powlson AS, et al. Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11 C-methionine PET co-registered with MRI. Eur J Endocrinol. 2016;175:485–98.

Article  CAS  PubMed  Google Scholar 

Bakker LEH, Verstegen MJT, Ghariq E, Verbist BM, Schutte PJ, Bashari WA, et al. Implementation of functional imaging using 11 C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery. Pituitary. 2022;25:587–601.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pruis IJ, Verburg FA, Balvers RK, Harteveld AA, Feelders RA, Vernooij MW et al. [ 18 F]FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary Tumors. Journal of Nuclear Medicine. 2024;jnumed.123.266853.

Heimburger C, Bund C, Addeo P, Goichot B, Imperiale A. 18F-FDOPA uptake reflects the efficacy of dopamine agonists treatment in Pituitary Prolactinoma. Clin Nucl Med. 2018;43:e324–5.

Article  PubMed  Google Scholar 

Ginet M, Cuny T, Schmitt E, Marie P-Y, Verger A. 18F-FDOPA PET imaging in Prolactinoma. Clin Nucl Med. 2017;42:e383–4.

Article  PubMed  Google Scholar 

Slagboom TNA, Stenvers DJ, van de Giessen E, Roosendaal SD, de Win MML, Bot JCJ et al. Continuing challenges in the definitive diagnosis of Cushing’s Disease: a structured review focusing on Molecular Imaging and a proposal for Diagnostic Work-Up. J Clin Med. 2023;12.

Muhr C. Positron Emission Tomography in Acromegaly and other Pituitary Adenoma patients. Neuroendocrinology. 2006;83:205–10.

Article  CAS  PubMed  Google Scholar 

Rodriguez-Barcelo S, Gutierrez-Cardo A, Dominguez-Paez M, Medina-Imbroda J, Romero-Moreno L, Arraez-Sanchez M. Clinical usefulness of Coregistered 11 C-Methionine Positron Emission Tomography/3-T magnetic resonance imaging at the Follow-Up of Acromegaly. World Neurosurg. 2014;82:468–73.

Article  PubMed  Google Scholar 

Bashari WA, Senanayake R, Koulouri O, Gillett D, MacFarlane J, Powlson AS, et al. PET-guided repeat transsphenoidal surgery for previously deemed unresectable lateral disease in acromegaly. Neurosurg Focus. 2020;48:E8.

Article  PubMed  Google Scholar 

Quinn M, Bashari W, Smith D, Gurnell M, Agha A. A remarkable case of thyrotoxicosis initially caused by graves’ disease followed by a probable TSHoma - a case report. BMC Endocr Disord. 2020;20:133.

Article  PubMed  PubMed Central  Google Scholar